Urachal mucinous adenocarcinoma: A case report

Panteleimon Kountourakis, A. Ardavanis, I. Mantzaris, D. Mitsaka, G. Rigatos

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Adenocarcinomas account for 0.5-2% of all bladder cancers. Urachal carcinoma is a rare neoplasm which represents 0.01% of all cancers in adults and account for one third of bladder adenocarcinomas. A 65-year-old white man with an urachal mucinous adenocarcinoma is reported. None of the known predisposing risk factors for bladder cancer -such as tobacco use and professional exposure to chemicals -were identified in his past medical history. The patient suffered from multiple sclerosis for almost 11 years and in the last 6 years he was treated with low doses of mitoxantrone. He underwent a partial cystectomy and en block excision of the umbilical ligament and remains disease-free after one year. The development of this rare neoplasm should not be clearly dissociated from multiple sclerosis, either aetiologically sharing an unidentified common causative factor or due to its treatment with mitoxantrone.

Original languageEnglish (US)
Pages (from-to)547-548
Number of pages2
JournalJournal of B.U.ON.
Issue number4
StatePublished - Oct 1 2007
Externally publishedYes


  • Mitoxantrone
  • Multiple sclerosis
  • Urachal adenocarcinoma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research


Dive into the research topics of 'Urachal mucinous adenocarcinoma: A case report'. Together they form a unique fingerprint.

Cite this